Ex Parte Boyd et alDownload PDFPatent Trial and Appeal BoardSep 26, 201613262493 (P.T.A.B. Sep. 26, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/262,493 09/30/2011 23909 7590 09/28/2016 COLGATE-PALMOLIVE COMPANY 909 RIVER ROAD PISCATAWAY, NJ 08855 FIRST NAMED INVENTOR Thomas Boyd UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. 8282-00-0C 2521 EXAMINER ARNOLD, ERNST V ART UNIT PAPER NUMBER 1613 NOTIFICATION DATE DELIVERY MODE 09/28/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): Patent_Mail@colpal.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte THOMAS BOYD, EVANGELIA ARV ANITIDOU, JOE VAZQUEZ, YING YANG, QING CLAIRE HE, and MARY HORCHOS 1 Appeal2014-001934 Application 13/262,493 Technology Center 1600 Before FRANCISCO C. PRATS, JACQUELINE T. HARLOW, and RICHARD J. SMITH, Administrative Patent Judges. PRATS, Administrative Patent Judge. DECISION ON APPEAL This appeal under 35 U.S.C. § 134(a) involves claims to exfoliating dentifrice compositions, systems including those compositions, and methods for their use. The Examiner rejected the claims for obviousness. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. STATEMENT OF THE CASE The sole rejection before us for review is the Examiner's rejection of claims 1--4 and 6-14 under 35 U.S.C. § 103(a) for obviousness over Moon 1 Appellants state that the "real party in interest in this appeal is Colgate- Palmolive Company." Br. 2. Appeal2014-001934 Application 13/262,493 et al., (WO 2007/091856 Al, published Aug. 16, 2007), Katayama et al., (EP 0 711 544 A2, published May 15, 1996), Szeles et al., (US 2003/0211054 Al, published Nov. 13, 2003), Melman (US 2002/0156130 Al, published Oct. 24, 2002), Doyle et al., (US 2005/0163727 Al, published July 28, 2005), Nathoo (US 2003/0103913 Al, published June 5, 2003), and Stone et al., (US 2006/0210511 Al, published Sept. 21, 2006). Final Action 2-11. Claim 1, the only independent claim on appeal, is representative and reads as follows (Br. 10): 1. An exfoliating dentifrice composition comprising (A) a plurality of granules, wherein the granules comprise at least one polymeric binding agent; (B) an orally acceptable vehicle, wherein at least one of the granules and the orally acceptable vehicle fi1rther comprises at least one abrasive agent and having an average particle diameter of 0.01 mm to 4 mm and comprises silica; and ( C) a hydroxyacid, wherein the granules further comprise a plasticizer selected from the group consisting of propylene glycol, glycerin and triacetin. OBVIOUSNESS In rejecting claims 1--4 and 6-14 for obviousness, the Examiner found that Moon described a dentifrice composition including nearly all of the features recited in claim 1, except that Moon did not disclose that its compositions included a hydroxyacid, and did not disclose whether the 2 Appeal2014-001934 Application 13/262,493 abrasive silica particles in its compositions had the average particle diameter required by claim 1. Final Action 4--5, 7. The Examiner cited Katayama as evidence of the obviousness of including, in dentifrice compositions, abrasive silica particles having the particle size required by claim 1. Id. at 5, 7. In particular, the Examiner reasoned that an ordinary artisan would have been motivated to include abrasive particles of the size taught in Katayama because clearly some particle size of the abrasive must be present in the composition of Moon et al. and therefore it is merely routine optimization of the particle sizes for abrasives in oral compositions to come up with an average particle diameter, such as the sizes taught by Katayama et al., to get an average size within the range of 0.01 mm to 4 mm by the ordinary artisan absent any criticality of the particle diameter. Id. at 8. As to the hydroxyacid also required by claim 1, the Examiner cited l\1elman evidence that hydroxyacids \~1ere kno\~1n in the art to be usefi1l in dentifrice compositions for the purpose of preventing the formation of plaque and dental caries, and for inhibiting tooth decay. Id. at 5. The Examiner reasoned that an ordinary artisan would have been prompted to include Melman's hydroxyacid in Moon's dentifrice compositions "at least [for] their additive effect with the anti-carie and agents for prevention of periodontal diseases of taught by Moon." Id. at 8. As to the remaining claims, all of which dependent from claim 1, the Examiner relied primarily on Moon, and cited the additional references to show the obviousness of including, in dentifrice compositions, features recited in those dependent claims. See id. at 5 (Szeles cited to show obviousness in dentifrices of proteolytic enzymes (Appellants' claim 7)); id. 3 Appeal2014-001934 Application 13/262,493 at 5---6 (Doyle cited to show obviousness in orally applied compositions of components recited in Appellants' claim 8 and application of such compositions by syringe as recited in Appellants' claim 9); id. at 6 (Nathoo cited as evidence of obviousness of "humectants such as glycerin, propylene glycol, polyethylene glycol, triacetin or any suitable mixture thereof'); id. at 7 (Stone cited as evidence of obviousness of using applicators recited in claim 12 to apply compositions to mucosal tissue). Appellants do not present separate arguments as to any of the claims subject to this ground of rejection. Accordingly, we select claim 1 as representative of the rejected claims. 37 C.F.R. 41.37(c)(l)(iv). As stated in Jn re Oetiker, 977F.2d1443, 1445 (Fed. Cir. 1992): [T]he examiner bears the initial burden . . . of presenting a prima facie case of unpatentability .... After evidence or argument is submitted by the applicant in response, patentability is determined on the totality of the record, by a preponderance of evidence with due consideration to persuasiveness of argument. Appellants' arguments do not persuade us that a preponderance of the evidence fails to support the Examiner's prima facie case of obviousness as to claim 1 . Appellants contend initially that the Examiner erred in finding that Moon describes a "dentifrice composition" as required by claim 1, because Moon describes tablet compositions which are not encompassed by Appellants' definition of "dentifrice" in i-f 8 of the Specification. Br. 3. We are not persuaded. Paragraph 8 of Appellants' Specification states that "[t]he term 'dentifrice' shall include toothpastes, gels, and rinses, alone or in 4 Appeal2014-001934 Application 13/262,493 combination. The dentifrice composition may be in any desired form, such as but not limited to deep striped, surface striped, multilayered, or any combination of gel and toothpaste." Spec. i-f 8 (emphasis added). Thus, rather than being limited to a toothpaste, gel, or rinse, as Appellants appear to suggest, the definition of "dentifrice" advanced by Appellants, by its terms, encompasses a composition "in any desired form," and is "not limited to" gels or toothpastes. Id. Indeed, i-f 8 of the Specification is not inconsistent with the Examiner's contention that the "plain and ordinary meaning of 'dentifrice' is any preparation for cleaning the teeth." Ans. 3. We acknowledge that Moon describes one of its compositions as a "tablet-type oral care composition ... prepared by compressing porous plastic granules at a pressure of 500 kg/cm2 or less and [which] undergoes in-situ melting and gelling by saliva or water in the buccal cavity, or by chewing." Moon, abstract. Because the broad definition of dentifrice in Appellants' Specification encompasses a teeth-cleaning oral composition in any desired form, Appellants do not persuade us that claim 1 fails to encompass Moon's oral care composition. To that end, as the Examiner points out (Final Action 4; Ans. 2), Moon discloses that "[l]ike conventional oral care products, the oral care agent of the present invention may be formulated into a gel-like oral care agent by placing the product on a toothbrush and flowing water thereto." Moon 26. In addition, Moon discloses that its "tablet composition is contrived to have a gel texture similar to that of conventional toothpaste." Id. at 5. Accordingly, Appellants do not persuade us that Moon fails to disclose a dentifrice composition encompassed by claim 1. 5 Appeal2014-001934 Application 13/262,493 Appellants contend further that the Examiner's rejection improperly picks and chooses only selected portions of the cited references to support the asserted conclusion of obviousness, and is therefore based on improper hindsight. Br. 4. In particular, Appellants contend, the Examiner mischaracterized the teachings from the cited references as they relate to Appellants' invention described in the Specification, as evidenced by the abstracts of each of the cited references. Id. at 4--7. Appellants contend that the Examiner did not explain adequately why the cited references would have suggested the claimed compositions. Id. at 7. In particular, Appellants contend, Moon intended to restrict the ingredients of the granules in its tablets to "a binder, a gelling agent and a water penetration enhancer (see e.g. page 4, lines 17-22 and claim 1 of Moon), i.e. even if it was permissible to pick and choose elements at random, Moon teaches away from making such arbitrary additions to their compositions." Id. We are not persuaded that the Examiner has improperly relied on hindsight to establish the obviousness of the composition of representative claim 1. Nor are we persuaded that an ordinary artisan would have had to sift through the collective disclosures of the cited references, or an infinite number of possible ingredient selections, to arrive at the composition of claim 1, as Appellants contend. Id. at 8. To the contrary, we are persuaded that the Examiner has explained adequately why, based on the teachings in the cited references, an ordinary artisan would have been prompted to prepare a composition having the ingredients required by representative claim 1. As the Examiner found (Final Action 4 (citing Moon's claims 1-3, 11 and13)), Moon describes a dentifrice composition that contains porous 6 Appeal2014-001934 Application 13/262,493 plastic granules composed of a polymeric binding agent, as claim 1 requires. See Moon 27 (e.g., claim 3 reciting a "tablet-type oral care composition ... consisting essentially of a material for porous plastic granules, a binder, a gelling agent, a water penetration enhancer, an anti-adhesive agent to teeth and a humectant"); see also Moon 28 (claim 11) (granules can include any of a number of polymeric binding agents, including cellulose derivatives). As to claim 1 's requirement for an orally acceptable vehicle, as well as claim 1 's requirement for a plasticizer selected from propylene glycol, glycerin, and triacetin, Moon discloses that the humectant in its compositions can be glycerin or propylene glycol. Moon 29 (claim 16). As also required by claim 1, and as the Examiner found (Final Action 4 ), Moon discloses that its compositions can include an abrasive composed of silica. Moon 14 ("An abrasive is very important for cleaning action of oral care products including removal of plaques, food debris, and the like ... . Currently, examples of materials for the abrasive suitable for use in oral care formulations may include silica .... "). Thus, as the Examiner found (Final Action 7), and Appellants do not persuasively dispute, Moon differs from Appellants' claim 1 only in not expressly teaching claim 1 's average particle diameter for the silica abrasive, and in not including a hydroxyacid. As the Examiner found, however (id. at 5), Katayama describes abrasive-containing dentifrice compositions (Katayama, abstract), teaches using silica particles as a water-insoluble abrasive in its compositions (id. at 4 ), and teaches also that an average particle size range of for those abrasive particles is from 50 to 500 µm (id. at 19 (claim 12)), a particle size range that undisputedly overlaps the average abrasive particle diameter range in 7 Appeal2014-001934 Application 13/262,493 Appellants' claim 1. We agree with the Examiner that an ordinary artisan, determining a suitable average particle diameter size for the silica abrasive included in Moon's compositions, would have considered it obvious to use abrasive silica particles within the size range taught in Katayama, given Katayama's teaching that abrasive particles of that size were suitable in dentifrice compositions. Because this suggestion comes from the cited prior art, rather than Appellants' Specification, Appellants do not persuade us that the Examiner's rationale in this respect is based on improper hindsight, or improper picking and choosing from the cited references. As to the hydroxyacid recited in Appellants' claim 1, as the Examiner noted (Final Action 4), Moon teaches that a number of additional active ingredients, beyond those in its most basic composition, would have been suitable in its formulations, including "an anti-caries agent, an anti-calculus agent, an agent for prevention of periodontal diseases, an antibacterial agent, an anti-inflammatory agent and a teeth whitening agent." Moon 29 (claim 17). Although Moon might not specifically mention a hydroxyacid as its active ingredient, as the Examiner found (Final Action 5), Melman discloses a composition that "successfully cleans and brightens teeth while inhibiting and reducing the growth of plaque bacteria, which is achieved when acetic acid or other equivalent organic acid is utilized in combination with conventional dental ingredients in effective concentrations to treat the oral cavity." Melman i-f 20 (emphasis added). Among organic acids taught by Melman as being useful for this purpose are lactic, glycolic, and salicylic acids (id. at i-f 17), all of which are undisputedly hydroxyacids encompassed by claim 1. See also Br. 9 (Appellants' claim 6). 8 Appeal2014-001934 Application 13/262,493 Given Moon's disclosure of the suitability in its dentifrice compositions of an anti-caries agent, an anti-calculus agent, an agent for prevention of periodontal diseases, an antibacterial agent, an anti- inflammatory agent, and/or a teeth whitening agent, and further given Melman's disclosure that hydroxyacids may be included in dentifrice compositions to provide formulations that clean and brighten teeth, and inhibit and reduce the growth of plaque bacteria, we agree with the Examiner that an ordinary artisan would have been prompted to include Melman's hydroxyacids in Moon's dentifrice compositions. Because this suggestion comes from the cited prior art, rather than Appellants' Specification, Appellants do not persuade us that the Examiner's rationale in this respect is based on improper hindsight, or improper picking and choosing from the cited references. Moreover, because Moon expressly teaches the suitability of including these types of active ingredients in its compositions, Moon's use of the language "consisting essentially of' when describing its compositions (see Moon 27 (claims 1-3)) does not persuade us that Moon teaches away from including additional active ingredients beyond the ingredients expressly recited in its claims 1-3. In sum, for the reasons discussed, Appellants' arguments do not persuade us that a preponderance of the evidence fails to support the Examiner's prima facie case of obviousness as to representative claim 1. Appellants do not advance secondary evidence of nonobviousness to rebut the Examiner's prima facie case. Accordingly, we affirm the Examiner's rejection of claim 1 for obviousness over the cited references. Because they were not argued separately, claims 2--4 and 6-14 fall with claim 1. 37 C.F.R. 41.37(c)(l)(iv). In that regard, we note Appellants' 9 Appeal2014-001934 Application 13/262,493 contention that, "[ w ]ith respect to a means of exfoliation and system claims, neither Moon nor any combination of references therof is directed toward this usage nor provides any evidence that they are able to achieve exfoliation given the different form of their composition or that a system was intended to be formed." Br. 7. Technically, however, to present separate argument regarding appealed claims, "[ u ]nder each heading identifying the ground of rejection being contested, any claim( s) argued separately or as a subgroup shall be argued under a separate subheading that identifies the claim( s) by number." 37 C.F.R. 41.37(c)(l)(iv). Appellants have not provided a separate subheading, as required. Nor have Appellants explained specifically, by number, which claims constitute the "means of exfoliation and system claims." Br. 7. In any event, we note that claim 10 recites "[a] method of exfoliating an oral cavity soft tissue comprising contacting an exfoliating dentifrice composition to an oral cavity soft tissue wherein the dentifrice composition is as defined in claim 1." Br. 10. We note also that claim 11 recites "[a] system for exfoliation of the soft tissues of the oral cavity comprising: (A) an oral care implement and (B) an exfoliating dentifrice composition according to claim 1." Id. As noted above, we agree with the Examiner that the cited references render obvious the dentifrice composition of claim 1, expressly recited in each of claims 10 and 11. As also noted above, Moon teaches that its composition should be combined with a toothbrush before use in the oral cavity as a dentifrice. See Moon 26. Thus, not only does Moon suggest applying its composition to the oral cavity as recited in Appellants' claim 10, 10 Appeal2014-001934 Application 13/262,493 but also suggests its combination with an oral care implement, as recited in claim 11. That Moon's suggestion for practicing the invention recited claims 10 and 11 might not be for Appellants' purpose of exfoliation does not render those claims any less obvious. See KSR Int'! Co. v. Teleflex Inc., 550 U.S. 398, 419 (2007). ("In determining whether the subject matter of a patent claim is obvious, neither the particular motivation nor the avowed purpose of the patentee controls. What matters is the objective reach of the claim. If the claim extends to what is obvious, it is invalid under§ 103."). SUMMARY For the reasons discussed, we affirm the Examiner's rejection of claims 1--4 and 6-14 under 35 U.S.C. § 103(a) for obviousness over Moon, Katayama, Szeles, Melman, Doyle, Nathoo, and Stone. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 11 Copy with citationCopy as parenthetical citation